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Changes in the human gastrointestinal microbiome are associated with several diseases. 20 
To infer causality, experiments in representative models are essential, but widely used 
animal models exhibit limitations. Here we present a modular, microfluidics-based 
model (HuMiX, human-microbial cross-talk), which allows co-culture of human and 
microbial cells under conditions representative of the gastrointestinal human-microbe 
interface. We demonstrate the ability of HuMiX to recapitulate in vivo transcriptional, 25 
metabolic and immunological responses in human intestinal epithelial cells following 
their co-culture with the commensal Lactobacillus rhamnosus GG (LGG) grown under 
anaerobic conditions. In addition, we show that the co-culture of human epithelial cells 
with the obligate anaerobe Bacteroides caccae and LGG results in a transcriptional 
response which is distinct from that of a co-culture solely comprising LGG. HuMiX 30 
facilitates investigations of host-microbe molecular interactions and provides insights 
into a range of fundamental research questions linking the gastrointestinal microbiome 
to human health and disease.  
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The human microbiome is emerging as a key player governing human health and disease1,2. 
Recent high-resolution molecular analyses have linked microbial community disequilibria 35 
(dysbiosis), primarily in the gastrointestinal tract (GIT), to several idiopathic diseases, 
including diabetes3, obesity4, inflammatory bowel disease5, cancer6 and, most recently, 
neurodegenerative diseases7. However, a detailed understanding of the fundamental molecular 
mechanisms underlying host-microbe interactions and their potential impact on immune 
regulation, drug metabolism, nutrition and infection remain largely elusive8,9. More 40 
specifically, patterns of association between distinct microorganisms, their traits and disease 
states resolved using ‘meta-omics’ do not allow direct causal inference, and thus, 
experimental validation is essential10. For this, robust experimental models that allow the 
systematic manipulation of variables are required to test the multitude of hypotheses that arise 
from the generated high-dimensional datasets10. Animal models used in human microbiome 45 
research are physiologically not representative11. In vitro models that mimic microbial 
processes along the gastrointestinal tract allow the simulation of luminal microbial 
communities12–14 and/or mucus-adherent microbiota15,16 but typically do not include 
provisions for assessing human host responses.  
Host responses to GIT microbiota have traditionally been assessed following the 50 
exposure of cultured human cells to bacteria-free supernatants17 or through short term direct-
contact co-cultures involving, for example, Transwell systems18, microcarrier beads19 or 
mouse gut organoid models20. Recent advances in multi-layer microfluidics have led to the 
development of a gut-on-a-chip model that includes a provision for peristalsis21 and that has 
been used to study intestinal inflammation on a chip22. These human-microbial co-culture 55 
approaches are, however, limited in their scope because they only allow experiments with 
commensal and/or mutualistic microorganisms growing under aerobic conditions21,22. To 
overcome these limitations, the recently introduced Host-Microbiota Interaction (HMI) 
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module, which interfaces with the in vitro Simulator of the Human Intestinal Microbial 
Ecosystem (SHIME) model, incorporates a semi-permeable membrane between co-cultured 60 
human enterocytes and bacteria23. Through inclusion of a partitioning membrane between the 
human and microbial culture chambers, the HMI module allows the co-culture of intestinal 
cells with complex microbial communities under microaerophilic conditions23. This two-
chamber design requires intermittent perfusion of the human cell culture medium to the apical 
surface of the epithelial cells, which is not representative of the continuous supply of nutrients 65 
to the basal membrane seen in vivo24–26. The lack of modularity makes it difficult to include 
additional cell types of relevance to the GIT in the HMI module, e.g. immune cells. 
Furthermore, it prevents the extraction of biomolecular fractions from the individual co-
cultured cell contingents following specific experimental regimes and thereby renders the 
HMI module incompatible with downstream high-resolution molecular analyses. Although 70 
the HMI module currently is the most representative in vitro model of gastrointestinal host-
microbial interactions, there still remains an unmet need for a modular, representative in vitro 
model of the gastrointestinal human-microbe interface.  
 Here, we present a modular microfluidics-based human-microbial co-culture model, 
HuMiX, which overcomes some of the limitations of existing in vitro models and allows the 75 
partitioned yet proximal co-culture of representative human and microbial cells followed by 
downstream molecular analyses of the individual cell contingents. More specifically, we 
demonstrate the viable co-culture of differentiated human epithelial cells (Caco-2) with either 
a facultative anaerobe, Lactobacillus rhamnosus GG (LGG), grown solely under aerobic or 
anaerobic conditions, or grown in combination with an obligate anaerobe, Bacteroides 80 
caccae, under anaerobic conditions. Co-culture experiments were followed by molecular 
analyses of the effects of the induced co-cultures on the physiology of human and bacterial 
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cells. Comparison of our results to published in vitro and in vivo datasets demonstrates the 
ability of HuMiX to representatively mimic the gastrointestinal human-microbe interface. 
 85 
Results & Discussion 
 
Design and characterization of the HuMiX model. To overcome the limitations of existing 
in vitro models10,23, we developed a modular microfluidics-based device, named HuMiX 
(human-microbial cross-talk), which allows the establishment of a model of the 90 
gastrointestinal human-microbe interface (Figs. 1a,b,c). The device consists of three co-
laminar microchannels: a medium perfusion microchamber (henceforth referred to as the 
“perfusion microchamber”), a human epithelial cell culture microchamber (henceforth 
referred to as the “human microchamber”) and a microbial culture microchamber (henceforth 
referred to as the “microbial microchamber”) (Figs. 1a,b and Supplementary Figure 1a,b). 95 
Each microchamber has a dedicated inlet and outlet for the inoculation of cells as well as for 
the precise control of physicochemical parameters through the perfusion of laminar streams of 
dedicated culture media (Figs. 1d,e). Dedicated outlets provide means to collect eluates from 
the individual chambers for downstream characterization (Figs. 1d and Supplementary Figure 
1a,b). By juxtaposing the human and microbial cell contingents at a distance of less than 1 100 
mm across a separatory nanoporous membrane, the HuMiX model is representative of a 
healthy intact epithelial barrier10 (Supplementary Note 1). Furthermore, the model integrates 
oxygen sensors (optodes) for the real-time monitoring of the dissolved oxygen concentrations 
within the device (Figs. 1a,b,d and Supplementary Figure 1c). Given the challenges associated 
with measuring transepithelial electrical resistance (TEER) on chip27, a specially designed 105 
version of HuMiX which allows the insertion of a commercial chopstick- style electrode 
(STX01; Millipore) was fabricated to monitor TEER for the characterization of cell growth 
and differentiation within the device (Figs. 1d and Supplementary Figure 1d).  
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 Following the conceptualization and engineering of the HuMiX model 
(Supplementary Note 1), we developed an optimized protocol for the co-culture of human 110 
epithelial cells with gastrointestinal microbes (Fig. 1e). The human cell line and bacterial 
isolates used for the co-culture experiments were originally obtained from the human large 
intestine and, together with the physical characteristics of the model (Supplementary Note 1), 
allowed the assembly of a model representing the human-microbe interface of the human 
colon. Nonetheless given the modularity of the device and the flexibility of its setup, other 115 
sections of the human GIT may be also modeled following appropriate modifications to the 
presented model (Supplementary Note 1). The protocol includes an extensive sterilization and 
handling protocol that enables the culture of human epithelial cells (Caco-2) in antibiotic-free 
DMEM medium to allow their subsequent co-culture with bacteria in HuMiX. The Caco-2 
cell line was chosen because it represents the most widely used model for the human 120 
gastrointestinal epithelial barrier as it exhibits essential functional and physiological traits of 
the intestinal epithelium25,28. The differentiation of the epithelial cells was evaluated by 
measuring TEER of the Caco-2 cell monolayer (Fig. 2a) and through microscopic observation 
of the expression of the tight-junction protein occludin (Fig. 2b).  
 Following the establishment of differentiated Caco-2 cell monolayers, we initiated co-125 
cultures of these cells with LGG (Supplementary Figure 2a). LGG of the phylum Firmicutes 
was chosen as it represents a commensal facultative anaerobic bacterium originally isolated 
from the human GIT29–31. Importantly, extensive data exists on its physiological impacts on 
mammalian mucosal tissues in vivo32–34. The developed co-culture protocol (Fig. 1e) first 
results in the establishment and maintenance of an epithelial cell monolayer. The Caco-2 cells 130 
adhere to the collagen-coated microporous membrane (Figs. 1a,e; Supplementary Note 1), 
proliferate and differentiate into confluent cell monolayers that form tight junctions between 
adjacent cells (Figs. 2a,b). The diffusion-based perfusion of the cell culture medium to the 
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basal side of the Caco-2 cells through the microporous membrane mimics the intestinal blood 
supply and provides shear-free conditions accelerating the growth of the human cells35.  135 
 Co-culture with LGG was initiated after seven days of epithelial cell culture (day 9 of 
the HuMiX co-culture protocol; Figs. 1e and 2a,b). This first involved the introduction of 
anaerobically grown LGG cell suspensions into the microbial microchamber through the port 
on a three-way connector (Fig. 1d). 
Following the co-culture, the modular device architecture allows access to individual 140 
cell contingents upon disassembly, whereby one half of each of the cell contingents can be 
used for microscopic evaluation and the other half can be used for the extraction of 
intracellular biomolecules (DNA, RNA, proteins and metabolites) for subsequent high-
resolution molecular analyses36. The viability of the co-cultured contingents was determined 
via live-dead staining and subsequent fluorescence microscopy, demonstrating that no 145 
apparent cytotoxic effects were induced in either cell contingent following their co-culture 
(Figs. 2c,d). RNA electropherograms confirmed that high-quality biomolecular fractions were 
obtained from the individual co-cultured contingents (Fig. 2e). 
Due to the laminar flow profiles within the microchambers, eluate samples (Fig. 2f) 
can be recovered from each microchamber, thereby providing a means to continually monitor 150 
the effects of the co-culture on the individual co-cultured cell contingents through various 
analyses, such as the use of cytokine assays and metabolomic profiling. Visible differences in 
the eluates from the three proximal microchambers support the notion of distinct 
microenvironments in each of the microchambers (Fig. 2f).   
Integrated oxygen sensors (optodes) allow continuous monitoring of the dissolved 155 
oxygen concentrations in the perfusion and microbial microchambers (Figs. 1e and 
Supplementary Figure 1c). The simultaneous perfusion of oxic (21% dissolved O2) and anoxic 
(0.1% O2) media through the perfusion microchamber and the microbial microchamber, 
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respectively, allowed the establishment and maintenance of an oxygen gradient representative 
of the in vivo situation (Fig. 2g). The measured dissolved oxygen concentrations in the 160 
perfusion microchamber stabilized to 5.43 ± 0.137% for the final 12 h of co-culture between 
the Caco-2 cells and LGG, which is comparable to the actual recorded concentrations in 
human intestinal tissues, i.e., 4.6%37 (Fig. 2g). The oxygen profiles in the microbial 
microchamber were characterized by a rapid decrease in the oxygen concentration (from 2.6% 
to ≤ 0.8% of dissolved oxygen) following an intermittent spike due to the introduction of 165 
small amounts of oxygen into the microbial microchamber during the inoculation process of 
LGG (Fig. 2g). The established anoxic conditions are analogous to those observed in vivo 
between the mucus layer and the luminal anaerobic zone (~ 0.88%)38 and such oxygen 
concentrations have been reported to be favorable for the growth of diverse microbiota, 
including obligate anaerobes39. The gradient of oxygen in the HuMiX model was maintained 170 
through the continuous perfusion of anoxic media (0.1%) into the microbial microchamber 
and further shaped by the consumption of oxygen by Caco-2 cells and the facultative 
anaerobe LGG (Fig. 2g).  
Through the consumption of oxygen, anaerobic niches are established in the microbial 
microchamber which subsequently allow colonization of the microbial microchamber by 175 
obligate anaerobes40. To showcase the ability of HuMiX to sustain culture of an obligate 
anaerobe, we initiated co-cultures using a simple microbial consortium comprising of LGG in 
combination with B. caccae (Supplementary Figure 2b and 3). B. caccae was chosen as it 
represents an obligate anaerobic commensal belonging to the phylum Bacteroidetes, the other 
dominant phylum apart from the Firmicutes (LGG) constituting the human GIT 180 
microbiome41. Both organisms were inoculated in equal starting proportions (OD ~ 1) and co-
cultured with Caco-2 cells for 24 h (Supplementary Figure 2b). The consortium was sustained 
via continuous perfusion of anoxic DMEM medium. The consortium structure was 
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determined using 16S rRNA gene amplicon sequencing after 24 h of co-culture and the 
relative abundances of Bacteroides spp. and Lactobacillus spp. were found to be 69% and 185 
31%, respectively (Fig. 2h). These results confirm the ability of the HuMiX model to support 
the growth of an obligate anaerobic microbial strain. Human cells still exhibited tight 
junctions (Supplementary Figure 3a) and both contingents were viable (Supplementary Figure 
3b,c). It follows from these experiments that the inclusion of more complex communities into 
the HuMiX model is possible but goes beyond the scope of the reported proof-of-concept 190 
experiments. 
Furthermore, to demonstrate the ability to incorporate other cell types within HuMiX, 
we cultured non-cancerous colonic cells, i.e. CCD-18Co in the human microchamber 
(Supplementary Figure 4a,b). Additionally, to demonstrate that HuMiX could be used in a 
three-layered setup for addressing specific research questions, we cultured primary CD4+ T 195 
cells for 48 h in the perfusion microchamber of HuMiX (Supplementary Figure 4c,d). The 
primary CD4+ T cells were cultured in the absence (Supplementary Figure 4c,d) or in the 
presence of LGG (Supplementary Figure 4e,f) over 48 h and did not exhibit any significant 
differences in terms of cell viability. These experiments highlight the potential of HuMiX to 
be used for investigating the cellular mechanisms involved in the interplay between GIT 200 
bacteria and different human cell types.  
In summary, HuMiX exhibits the following essential characteristics: (1) modular 
microfluidic device architecture consisting of three microchambers engineered to facilitate the 
proximal co-culture of human and microbial cells, (2) ability to perfuse the device with 
dedicated culture media to allow the establishment of aerobic conditions for human cell 205 
culture and anaerobic conditions for GIT bacteria, (3) real-time monitoring of oxygen 
concentrations, (4) easy access to the individual cell contingents following specific 
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experimental regimes, and (5) compatibility with end-point microscopic assays as well as 
high-resolution multi-omic analyses. 
 210 
HuMiX-based co-cultures induce in vivo-like physiological responses in Caco-2 cells. 
Given the demonstrated ability to establish conditions representative of the human 
gastrointestinal tract in HuMiX, we conducted further validation experiments to assess the 
human cellular responses to co-culture conditions in HuMiX. LGG has been widely used in 
several human clinical trials aimed at understanding the efficacy of probiotic treatments in 215 
humans32,33. More specifically, gene expression differences have been documented in human 
intestinal mucosal biopsy samples after the administration of LGG to either healthy subjects32 
or as a therapeutic supplement for male individuals suffering from esophagitis33. Therefore, to 
validate our in vitro co-culture approach, we performed detailed experiments involving the 
co-culture of Caco-2 cells maintained under aerobic conditions with LGG cultured under 220 
anaerobic conditions (Supplementary Figure 2a) and compared the resulting Caco-2 gene 
expression data with reference data from clinical studies32,33. For this, total RNA was first 
extracted from Caco-2 cells following their co-culture with LGG grown under anaerobic 
conditions as well as their corresponding LGG-free controls (anoxic medium was perfused 
through the microbial microchamber, but no bacteria were inoculated, Supplementary Figure 225 
2a). The RNA was then subjected to DNA microarray-based mRNA and miRNA profiling.  
Overall, we identified 208 genes that were differentially expressed following co-
culture with LGG grown under anaerobic conditions [fold-change (=FC) > 1.5 and 
equivalently with swapped conditions for decreased expression, P < 0.01, empirical Bayes 
moderated t-statistic (BtS), Figs. 3a and Supplementary Figure 5a, Supplementary Table 1]. 230 
Given the lack of detail regarding the identities of genes found to be differentially expressed 
in vivo, we limited our subsequent analyses and discussions to genes that were explicitly 
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highlighted in the in vivo clinical studies and that showed statistically significant differences 
in our study (Table 1). Among the top differentially expressed genes, we validated the gene 
expression of four genes—ccl2, pi3, egr1 and mt2a—using RT-qPCR analyses. The RT-qPCR 235 
results showed differential expression patterns analogous to those observed in the microarray 
data (Supplementary Figure 5b).  
Our transcriptomic results exhibit a high level of concordance between the LGG-
treated human mucosal in vivo transcriptomic data and the differentially expressed gene sets 
identified through the comparison of HuMiX-based co-cultures with LGG grown under 240 
anaerobic conditions compared to the corresponding LGG-free controls32,33 (Table 1 and 
Supplementary Figure 5a). The co-culture involving LGG in HuMiX resulted in the up- and 
down-regulation of 127 and 81 genes in the Caco-2 cells, respectively (Supplementary Table 
1, FC > 1.5 and P < 0.01, BtS). Importantly, the co-culture of Caco-2 with LGG resulted in 
the differential expression of eight genes [egr1, ccl2, slc9a1, ubd, cxcr4, mybl2, pim1 and 245 
cyp1a1 (Table 1, Supplementary Figure 5a, Supplementary Note 2; P < 0.05, BtS)], which 
had also been found to be differentially expressed in human intestinal biopsy samples after the 
administration of LGG32,33. In addition to the genes described above, we also identified four 
(elf3, cdk9, gadd45b and pilrb) genes, previously highlighted as responsive to LGG in human 
subjects32,33 (Table 1), but the expression of these genes was found to be disparate when 250 
comparing our results to the in vivo expression data (Table 1). The highlighted differences in 
the expression of these four genes are likely due to the reduced complexity of the 
microenvironment, the human epithelial cells and the microbiota used in our proof-of-concept 
experiments compared to the in vivo situation. Additionally, we found a high degree of 
concordance in responsive pathways (e.g. IFN response, calcium signaling and ion 255 
homeostasis) in Caco-2 cells following their co-culture with LGG grown under anaerobic 
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conditions and the available in vivo mucosal transcriptomic data32,33 (Supplementary Table 2 
and 3, Supplementary Note 3).  
The inoculation of HuMiX with LGG is more similar to the primocolonization of 
germ-free animals than its introduction into an already mature GIT microbiome. At present, 260 
the only systematic in vivo study highlighting the host transcriptomic response to the 
primocolonization by LGG was conducted in germ-free piglets34. In accordance with findings 
from the latter study, our data also highlights a differential expression in eight genes (all P < 
0.03, BtS, Table 1, Supplementary Note 4), which also exhibited an altered transcriptional 
response in mucosal tissues of gnotobiotic piglets 24 h after their inoculation with LGG34.  265 
 Caco-2 cells are known to secrete distinct cytokines analogous to immune cells when 
they are challenged with different microbial stimuli. More specifically, the secretion of the 
pro-inflammatory cytokines IL-8 and CCL20 by Caco-2 cells following direct co-culture with 
microbial strains42,43 or the application of cell-free microbial supernatants and/or other 
microbial products is well established44. Consequently, they represent a good model for 270 
assessing the specific immunological responses to different microorganisms and their 
products18. Therefore, we sampled eluate from the perfusion microchamber (which is in 
contact with the basal side of the Caco-2 cells) before and 24 h after co-culture with LGG 
grown under anaerobic conditions, and we screened for immunological markers, including IL-
8 and CCL20 (Fig. 3b). No statistically significant increase [paired Student’s t-test (StT); P < 275 
0.3] but an apparent slight decrease (Fig. 3b) in the pro-inflammatory cytokines released by 
the human epithelial cells was observed when they were co-cultured for 24 h with LGG. This 
observation (Fig. 3b) is in agreement with previous findings, suggesting a subtle anti-
inflammatory effect by LGG on human epithelial cells44.  
 In addition to the highlighted cytokine and transcriptional responses of Caco-2 cells, 280 
the proximal co-culture of host and microbial cells has the potential to elucidate the complex 
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molecular crosstalk that may induce metabolic changes in the host and microbial cells. Hence, 
in order to demonstrate the potential of HuMiX for investigating metabolic interactions 
between human and microbial cells and for assessing the impact of co-culture on human 
cellular metabolism, we conducted metabolomic analyses of the intracellular metabolite 285 
fractions from the Caco-2 cells when these were co-cultured with LGG growing under 
anaerobic conditions (Fig. 3c). After 24 h of co-culture, of the 313 metabolites detected, 214 
[14 of which were statistically significant (P < 0.1, StT)] were more and 99 [5 of which were 
statistically significant (P < 0.1, StT)] were less abundant in the co-cultured Caco-2 
intracellular metabolite fractions when compared to their levels in the corresponding controls 290 
(Supplementary Table 4). 68 % of metabolites could not be identified using available 
metabolite databases. 5 unknown metabolites which were present in control samples were not 
detected in the Caco-2 metabolite fractions following co-culture. The intracellular levels of 
certain TCA cycle intermediates increased. In particular, the intracellular concentrations of 
fumaric acid (FC > 3, P < 0.05, StT), citric acid (FC > 6, P < 0.05, StT) and isocitric acid (FC 295 
> 6, P < 0.07, StT; Fig. 3c) increased significantly (Supplementary Table 4). Interestingly, the 
increase in TCA cycle intermediates agrees with the previous observations of similar 
increases in the blood serum of germ-free mice upon their conventionalization45.  
Furthermore, the apparent decrease in intracellular concentrations of urea (FC > 2, P < 
0.2, StT; Supplementary Table 4) after inoculation with LGG was analogous to earlier reports 300 
describing the induced metabolic changes following the conventionalization of germ-free 
mice45. Our transcriptomic data further revealed that the cps1 gene was downregulated in 
Caco-2 cells following their co-culture with LGG grown under  anaerobic conditions (Figs. 5a 
and Supplementary Figure 8, FC > 1.4, P < 0.05, BtS). The CPS1 protein is the first and rate-
limiting step of the urea cycle that converts ammonia to carbamoyl phosphate. CPS1 has 305 
 
 
14
previously been found to be expressed in intestinal epithelial cells46, and our results suggest 
that microbiome-mediated modulation of ureagenesis may occur in the GIT.  
 Analogous to the experiments involving Caco-2 cells, we also conducted a 
metabolomic investigation of the intracellular LGG metabolite fractions after co-culture with 
Caco-2 cells and compared the results to those derived from mono-cultured LGG to further 310 
investigate cross-talk between the Caco-2 cell and LGG. Interestingly, 170 intracellular 
metabolites (representing 47% of all metabolites detected) were reduced or even undetectable 
after the co-culture with Caco-2 cells (P < 0.05, StT; Supplementary Figure 6, Supplementary 
Table 5). Furthermore, fumaric acid was one of the metabolites under the detection limit after 
co-culture with Caco-2 cells (P < 0.05; Supplementary Table 5). The concomitant increase in 315 
the intracellular fumaric acid concentration in the Caco-2 cells (Fig. 3c) suggests possible 
cross-feeding of this metabolite between the Caco-2 and the LGG cells. Furthermore, this 
suggests that the catalytic activity of the enzyme succinate dehydrogenase might be 
differentially regulated in bacteria compared to human cells upon their co-culture. Most of the 
metabolites detected (77%) did not result in a direct match in the available databases 320 
(Supplementary Figure 6a). Interestingly, 51 of those metabolites were only discovered in the 
mono-cultured LGG but were not discovered in the intracellular LGG metabolites fraction 
after co-culture with Caco-2 cells (P < 0.05, StT; Supplementary Table 5). Intriguingly, three 
unknown (no match) metabolites were detectable in the intracellular LGG pool only after the 
co-culture with Caco-2 cells (P < 0.05, StT; Supplementary Table 5). These results suggest 325 
significant shifts in LGG metabolism owing to extensive cross-feeding with the human 
epithelial cells. Our results further confirm that despite of the presence of a partitioning 
nanoporous membrane between the epithelial cells and LGG in the HuMiX model, there 
exists an efficient crosstalk between the human and microbial cells as demonstrated by the 
induction of physiological responses in both human epithelial and bacterial cells. 330 
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Taking into account in particular the concordance between the transcriptional 
responses of the epithelial cells co-cultured with LGG in HuMiX and in vivo expression data 
obtained from human and piglet studies, the presented results validate the HuMiX model and 
support the notion that this model may be regarded as an alternative to animal models for 
first-pass experiments aimed at elucidating host-microbial molecular interactions and their 335 
effects on the host.  
Responses of Caco-2 cells following co-culture with a bacterial consortium. In order to 
evaluate the effect of a bacterial consortium on Caco-2 cells, B. caccae and LGG were both 
placed in co-culture with Caco-2 cells whereby the bacterial consortium was maintained 
under anaerobic conditions (Supplementary Figure 2b). The addition of B. caccae lead to a 340 
significant change in the transcriptional response of the Caco-2 cells in comparison to the 
response when Caco-2 cells were co-cultured with only LGG (Fig. 4a).  
Interestingly, following the inclusion of B. caccae, only 6 genes (slc9a1, elf3, mybl2, 
gadd45b, igfbp2, gsta1) out of the previously highlighted 19 genes (Table 1) that showed 
differential gene expression under an LGG anaerobic co-culture regime as well as in the in 345 
vivo human clinical studies32–34 were identified to be differentially expressed in the Caco-2 
cells. However, three additional Caco-2 genes (ndrg3, hmgcs2, cyr61, all FC > 1.5, P < 0.08; 
Supplementary Note 5) earlier highlighted in human clinical trials to be differentially 
expressed after LGG administration where found to be differentially expressed only after co-
culture with LGG and B. caccae which suggests that consortium-driven synergistic 350 
mechanisms are likely at play32,33 (Supplementary Table 6). Overall, we found that 1,638 
human genes exhibited differential expression specifically when Caco-2 cells were co-
cultured with LGG and B. caccae compared to 856 genes which were differentially expressed 
by Caco-2 cells when solely co-cultured with LGG (Fig 4b; P < 0.01, BtS). 111 genes showed 
a similar expression pattern under both co-culture conditions (Fig 4b; P < 0.01, BtS).  355 
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Furthermore, we analyzed the intracellular metabolite fractions of the Caco-2 cells to 
determine the induced effects as a result of the co-culture regimes involving LGG and B. 
caccae (Fig. 4c). Analogous to the transcriptional response, the intracellular metabolite 
fractions of the Caco-2 cells were significantly altered in response to the consortium co-
culture as compared to the cells co-cultured solely with LGG (Fig. 3c; Supplementary Table 360 
7). Our results demonstrate that the HuMiX model is capable of capturing transcriptional and 
metabolic responses of the human epithelial cells in response to changes to the composition of 
the co-cultured microorganisms.  
 
Transcriptional responses of Caco-2 cells following co-culture with LGG grown under 365 
either aerobic or anaerobic conditions. Since HuMiX offers the possibility to co-culture 
human cells with bacteria growing under anaerobic conditions (i.e., mimicking the conditions 
in the gastrointestinal tract), we explored the potential benefits of such co-cultures in contrast 
to traditional co-culture approaches which maintain bacteria under aerobic conditions10, which 
are likely to induce non-representative changes in bacterial metabolism31 and consequential 370 
effects in human cells. For this, we compared the gene expression patterns of Caco-2 cells 
following 24 h of co-culture with LGG grown under anaerobic conditions (≤ 0.8% dissolved 
oxygen) or aerobic conditions (21%) (Figs. 5a,b and S2c). 
The generic Caco-2 response to co-culture with LGG was first determined by focusing 
on the genes that exhibit similar expression patterns under both LGG culture conditions 375 
compared to their respective LGG-free controls (Supplementary Figure 2a,c and 
Supplementary Figure 7). Ninety-four genes exhibited differential expression under either of 
the two co-culture conditions (Figs. 5b and Supplementary Figure 7; P < 0.01, BtS). 
Conversely, genes that were differentially expressed under either condition were determined 
to be specific to one of the two conditions, i.e., LGG grown under anaerobic conditions or 380 
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aerobic conditions. Overall, we identified 492 human genes that exhibited differential 
expression specifically when Caco-2 cells were co-cultured with LGG growing under 
anaerobic conditions, whereas twenty genes were specifically expressed by Caco-2 cells co-
cultured with aerobically growing LGG (Figs. 5a,b and Supplementary Figure 8; P < 0.01, 
BtS).   385 
Among the top differentially expressed genes in Caco-2 cells when co-cultured with LGG 
grown under anaerobic conditions, we identified four human genes [ccl2 (P < 0.001), egr1 (P 
< 0.005), ubd (P < 0.05), slc9a1 (P < 0.05)] that exhibited expression patterns identical to 
those observed in mucosal biopsy samples obtained from healthy human subjects following 
the administration of the probiotic LGG (Figs. 5a and Supplementary Figure 8 and Table 1; 390 
all FC > 1.5, BtS)32,33. Intriguingly, when the Caco-2 cells were co-cultured with LGG 
growing under aerobic conditions instead, these genes were either up- or down-regulated in 
one co-culture versus control pair situation, and exhibited the opposite trend in the other 
scenario (Figs. 5a and Supplementary Figure 8). Among the genes which presented such 
opposing expression patterns, we identified a number of genes which play important roles in 395 
regulation of inflammatory responses, maintenance and regulation of epithelial barrier 
function, mediation of host-microbe interactions and regulation of cancer-related pathways 
(Supplementary Figure 8 and Supplementary Note 6). Additionally, we found four genes 
(cxcr4, pim1, cyp1a1 and mybl2, P < 0.05, BtS), which had previously been identified in 
human clinical trials to be differentially expressed in the presence of LGG32,33, to exhibit a 400 
more generic response to co-culture with LGG, i.e., similar expression in Caco-2 cells when 
co-cultured with LGG under either condition (Supplementary Figure 7 and Table 1). The 
differential expression of cancer-related genes in cancer-derived Caco-2 cells following their 
co-culture with LGG is interesting and further investigations are required to determine 
whether this is a generic response by human epithelial cells or whether this is limited to 405 
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cancer-derived cells. In all of the presented results, as the gene expression profiles of the co-
cultured cells have been compared to mono-cultured Caco-2 cells, the effects observed are 
attributable to the influence of the co-cultured bacteria on the Caco-2 cells.  
 To further define the effects of LGG on Caco-2 cells when LGG was grown in two 
distinct oxygen conditions, a pathway enrichment analysis was conducted this time using only 410 
the Caco-2 genes that exhibited contrasting gene expression patterns (the threshold parameters 
used were FC > 1.5 and P < 0.05, BtS, Supplementary Table 9). The pathways which 
exhibited differential expression based on the contrasting gene expression patterns were 
linked to gut motility, immune response, cell cycle, cell adhesion, apoptosis, cytoskeleton 
remodeling, lipid metabolism regulation, signal transduction and developmental signaling 415 
pathways (Supplementary Table 9, Supplementary Note 6). An additional data-driven 
pathway analysis using the Gene Ontology database revealed that the top enriched pathways 
exhibiting contrasting gene expression patterns under anaerobic or aerobic conditions were 
related to metabolism (more specifically lipid, protein and carbohydrate metabolism), cellular 
homeostasis, amino acid transport, and particularly adaptive immune responses 420 
(Supplementary Table 10, Supplementary Note 6).  
Given the pivotal role of anaerobic conditions in the GIT for the maintenance of the 
GIT microbiota composition47, host-microbe mutualistic interactions48 and possibly 
dysbiosis49, these obtained results represent an important validation of the HuMiX approach 
for representative studies of host-microbe interactions. Based on these results, the existing 425 
models, which typically involve the co-culturing of bacteria and human cells under aerobic 
conditions, induce a partial and partly non-representative transcriptional response in Caco-2 
cells and this highlights the importance of maintaining anaerobic culture conditions when co-
culturing GIT bacteria with human cells. The ability to maintain bacteria under anaerobic 
conditions therefore represents a key functionality of the HuMiX model.  430 
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The potential of HuMiX for discovery-driven investigations of host-microbe 
interactions. Although the primary purpose of our experimental work was to validate the 
HuMiX model in relation to already existing knowledge primarily from in vivo studies, our 
multi-omic data also potentially allow novel insights in the context of host-microbe molecular 
interactions. More specifically, the opportunity to comprehensively mimic and probe the 435 
individual cell contingents using high-resolution molecular analyses provides an 
unprecedented opportunity to study the effects of live bacterial cells growing under 
representative environmental conditions in close proximity to human cells. Here, we describe 
interesting observations obtained following the co-culture of Caco-2 cells with LGG or with 
the LGG and B. caccae consortium when these were maintained under anaerobic conditions. 440 
 
Co-cultured microorganisms alter expression of miRNAs linked to colorectal cancer in Caco-
2 cells. Following co-culture with LGG or LGG with B. caccae grown under anaerobic 
conditions, miRNA profiling highlighted differential regulation of a vast number of miRNAs 
(mir483-3p, mir1229-3p, mir92b, mir1915, mir30b-5p, mir4521, mir193a-5p, mir125a-5p and 445 
mir141-3p) linked to colorectal cancer (Fig. 6). Notably, many of these have been recently 
added to panels of biomarkers for diagnosis and prognosis of gastrointestinal cancers50–54. 
Many of these miRNAs were only differentially expressed in the presence of LGG while the 
expression of others was altered by the presence of B. caccae in the consortium. Despite the 
fact that Caco-2 cells are cancer-derived, our results demonstrate that the presence of different 450 
bacteria leads to a differential regulation of the expression of these cancer-related miRNAs. 
These results underpin the notion that HuMiX may prove valuable as a screening tool for 
identifying and validating biomarker signatures (Supplementary Note 7) and for testing 
microbiome-based therapeutic interventions for example in the context of colorectal cancer. 
 455 
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LGG induces the accumulation of GABA in epithelial cells. The intracellular accumulation of 
GABA (4-aminobutanoic acid) in Caco-2 cells following co-culture with LGG grown under 
anaerobic conditions (Fig. 3c, FC = 2.18, P < 0.06, StT; Supplementary Note 8) is similar to 
previous observations in pulmonary epithelial cells55, in which GABA was found to 
contribute to the relaxation of smooth muscle tone56. ccl2 (FC > 1.5, P < 0.001, BtS), ranked 460 
among the top 10 differentially expressed  genes in our co-culture experiments (Table 1) as 
well as in vivo transcriptomic data following LGG administration32,33, has been shown to 
interact with GABA and to contribute to the regulation of the GABAergic response in 
neurons57. Additionally, gad1 gene was slightly upregulated following the co-culture of Caco-
2 cells with LGG grown under anaerobic conditions (Supplementary Figure 7, FC ~ 1.2, P < 465 
0.05, BtS). gad1 encodes one of several forms of glutamic acid decarboxylase that catalyzes 
the conversion of L-glutamic acid into GABA and may thus be involved in the marked 
increase in the intracellular GABA concentrations in Caco-2 cells. The exact mechanism of 
GABA accumulation in the Caco-2 cells in our experiments and its potential local and 
systemic effects in vivo are important research questions for future HuMiX-based 470 
investigations but go beyond the scope of the present study. Given its modularity and 
flexibility for inclusion of additional cell types, the HuMiX model may allow detailed 
investigations of the molecular mechanisms governing the gut-brain axis in the future.  
 
Conclusion. Our experimental results demonstrate that HuMiX is a representative model of 475 
the gastrointestinal human-microbe interface as individual transcriptional responses from 
human epithelial cells co-cultured with LGG inside HuMiX are in accordance with in vivo 
data. HuMiX also allows discovery-based studies particularly in relation to proving causal 
relationships between gastrointestinal microbiota and human diseases. Although HuMiX was 
developed with a focus on host-microbe interactions, it may find applications in a number of 480 
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other domains including drug screening, drug discovery, drug delivery, pharmacokinetics and 
nutritional studies. The ability to co-culture human and microbial cells in a controlled manner 
and perform systematic investigations of such co-cultures opens up numerous avenues for 
basic and applied research in the context of the human microbiome in the future. 
  485 
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Methods 
Fabrication and assembly of the HuMiX device. The HuMiX device is comprised of two 
polycarbonate (PC) enclosures, which sandwich silicone rubber gaskets, which are 
themselves attached to semi-permeable PC membranes (Figs. 1b and Supplementary Figure 
1a,b). PC was chosen because it is easy to machine, can be sterilized by autoclaving and is 490 
gas impermeable, which is essential for controlling the oxygen concentrations within the 
device. The enclosures were fabricated by computer numerically controlled milling of 6.2 
mm thick polycarbonate sheets (Professional Plastics). Towards their inner side, the 
enclosures have machined pockets for inclusion of optical sensor spots (optodes) for oxygen 
sensing (Figs. 1b and Supplementary Figure 1c) and perforations, which allow the bolting of 495 
the device together (Figs. 1b and Supplementary Figure 1a). To delineate the individual 
spiral-shaped microchambers (Figs. 1c and Supplementary Figure 1b), 0.79 mm thick super-
soft silicone sheets were laser-cut to form gaskets. Medical-grade double-sided adhesive 
tapes (Adhesives Research Inc.) were attached to the gaskets and to these were then affixed 
the semi-permeable PC membranes. The perfusion microchambers were assembled by 500 
attaching a 1 μm pore size PC membrane (Whatman, GE Healthcare) to the gasket, whereas a 
50 nm pore size PC membrane (Whatman, GE Healthcare) was attached to the gasket 
delineating the human microchamber from the microbial microchamber. For assembly, the 
gaskets were precisely aligned and sandwiched between the top and bottom enclosures. The 
HuMiX devices were then bolted together using M2 screws and nuts (McMaster-Carr). A 505 
special version of the HuMiX device with additional side pockets was also fabricated to 
allow insertion of the industry standard chopstick style STX2 electrode (WPI Inc.) to 
characterize the growth of epithelial cells inside the device (Supplementary Figure 1d). The 
gaskets with the attached membranes are disposable and cannot be reused. The PC enclosures 
can be reused after proper sterilization.  510 
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Sterilization of the HuMiX device. A robust sterilization procedure was developed and 
optimized to completely avoid both fungal and bacterial contamination in any of the 
microchambers. All the parts (enclosures, gaskets, screws, nuts, syringe needles, peristaltic 
pump tubings, media bottles, etc.) and materials (handling equipment, mucin, etc.) used for 
the assembly and testing of the HuMiX device were autoclaved at 110°C for 60 min. Prior to 515 
assembly of the tubings as well as the HuMiX device, the PC enclosures were thoroughly 
cleaned with 70% v/v ethanol followed by air-drying under a laminar flow hood. Dead-ended 
(knotted) silicone tubings were attached to the inlet and outlet connectors (Supplementary 
Figure 1c) during autoclaving to keep the connector vias sterile during handling and 
assembly. Additionally, the PC enclosures were also exposed to UV for 10-20 min under a 520 
laminar flow bench before assembly. 
 
Coating of the membranes and permeability assays. After autoclaving, the 1 μm pore-size 
PC membranes, affixed to the gaskets, were coated using 4 ml of 50 μl/ml rat tail collagen 
solution (Life Technologies; prepared in 0.02 M acetic acid) for 3 h. The collagen stock 525 
solution was sterilized by layering the solution over 10% (v/v) chloroform overnight at 4°C, 
after which, the top collagen layer was aseptically removed58. The 50 nm pore-size PC 
membranes were covered with autoclaved 0.025 mg/ml porcine gastric mucin (Sigma 
Aldrich) solution for 1 h. Excess solution was removed after the coating procedure and the 
membranes were air dried for 30 min under sterile conditions. The thickness of the mucin 530 
layer was characterized using confocal laser scanning microscopy by embedding 4 kDa FITC 
conjugated dextran (Sigma Aldrich) in the mucin solution23. For the characterization of the 
permeability of the HuMiX setup, a HuMiX device was assembled with coated micro and 
nanoporous membranes. A water solution containing 4 kDa FITC conjugated dextran was 
perfused into the microbial microchamber and intermittent samples were collected from 535 
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perfusion microchamber at regular intervals to determine the permeability of the HuMiX 
device as described in Marzorati et al.23.  
Maintenance of cells and microbial cultures. The human epithelial colorectal cell line 
Caco-2 (DSMZ: ACC169) and non-cancerous colonic cell line CCD-18Co (ATCC CRL-
1459™) were maintained at 37°C in a 5% CO2 incubator in DMEM medium (Sigma-Aldrich) 540 
supplemented with 20% fetal bovine serum (FBS; Life Technologies) and 1% Penicillin-
Streptomycin (PS) (Sigma-Aldrich) until use and passaged at 80-100% confluence. Only 
cells between passages 7−28 were used for this study. Primary CD4+T cells were purified 
from healthy blood donors (Red Cross Luxembourg) via magnetic labeling and subsequent 
separation on an LS column (Miltenyi Biotech). Prior to inoculation of the immune cells into 545 
HuMiX they had been activated with IL-2 (10 ng/ml), CD3 antibodies (5 μg/ml) and CD28 
antibodies (5ug/ml) for 24 h.  
Lactobacillus rhamnosus GG (ATCC: 53103) was cultured in aerobic as well as 
anaerobic DMEM medium supplemented with 20% FBS without antibiotics in a shaking 
incubator at 37 °C and 200 rpm. Bacteroides caccae (DSMZ: 19024) was cultured in anoxic 550 
DMEM medium supplemented with 20% FBS and haeme or HBIB medium. Prior to 
inoculation in HuMiX device, the microbial suspensions were pelleted and washed with 0.9% 
NaCl before suspending them in 5 ml fresh anoxic DMEM medium. The microbial 
suspensions were mixed in equal proportions a prior for consortium co-cultures with the 
Caco-2 cells in HuMiX. Fresh microbial cultures were started from glycerol stocks and 555 
cultured for 6-24 h prior to inoculation into the HuMiX device.  
  
HuMiX co-cultures using Caco-2 cells. Before inoculation of the Caco-2 cells into the 
HuMiX device, the tubings (peristaltic pump tubes as well as the tubes to be later connected 
to the HuMiX devices) were connected to 0.5 l serum bottles (Glasgerätebau Ochs) 560 
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containing the culture media (Fig. 1d). The HuMiX device was then integrated into the tubing 
setup by attaching the elastomeric tubing to the connectors of the HuMiX device. To prime 
the HuMiX device, DMEM medium supplemented with 20% of FBS was perfused at 0.65 
ml/min through all the channels of the HuMiX device using a programmable 205CA 
peristaltic pump (Watson Marlow). After priming of the HuMiX setup to remove air bubbles, 565 
the entire setup was shifted to a 5% CO2 incubator set to 37 °C. At this moment in time, the 
flow rate was reduced to 5 μl/min for at least 1−2 h to equilibrate the entire HuMiX device 
and coat the chamber with medium constituents to improve subsequent cell adhesion. 
Following equilibration, the HuMiX device and tubing setup was moved back to the laminar 
flow bench and inoculated with human epithelial cells (Caco-2) by injecting a 1 ml cell 570 
suspension (6 x 105 cells / ml) into the human microchamber using a sterile syringe (Becton 
Dickinson Discardit™) via a Discofix 3-way adapter (B.Braun). Subsequently, the HuMiX 
device was flipped and incubated at 37 °C without flow for 2 h to allow attachment of cells to 
the collagen-coated microporous membrane. After 2 h, the Caco-2 cells were perfused at their 
basal side via the perfusion microchamber with DMEM medium supplemented with 20% 575 
FBS at a flow rate of 25 μl/min. Perfusion through the microbial microchamber was 
simultaneously initiated. If the Caco-2 cells were later to be co-cultured with LGG or LGG 
and B. caccae grown under anaerobic conditions, perfusion with anoxic DMEM medium was 
carried out at the same flow rate of 25 μl/min. Anoxic DMEM medium was obtained by 
constantly bubbling the medium with dinitrogen gas through an aeration needle placed inside 580 
the media bottle (B.Braun). For each microbial culture condition (LGG growing either under 
anaerobic or aerobic conditions, Supplementary Figure 2a,c), bacterial cells were introduced 
into the microbial microchamber on day 7 following initiation of the Caco-2 cell culture. At 
day 7, the Caco-2 cells were found to have formed tight junctions (Fig. 2b) and the cell 
number (~1 x 106) had reached a value allowing downstream molecular analyses. The LGG 585 
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or LGG and B. caccae cell suspensions were then introduced into the microbial 
microchamber using a Discofix 3-way adapter in a 1 ml suspension (OD~1) and later 
perfused with  anoxic or oxic DMEM medium at 25 μl/min. Following 24 h of co-culture, the 
devices were disassembled and the human and microbial gaskets were separated. For further 
detailed analyses, the gaskets were divided into 3 parts, whereby half of the cell-covered 590 
membranes were used for extraction of the intracellular metabolites, DNA, RNA and proteins 
using a comprehensive biomolecular extraction protocol36. The other two quarters were used 
for live-dead staining (Calbiochem Millipore staining kit and L7007 BacLight microbial 
viability kit Molecular Probes) as well as immunostaining for subsequent fluorescence 
microscopy. As controls, Caco-2 and LGG were cultured individually on separate devices. 595 
The co-culture protocol is graphically depicted in Figure 1e. 
 
HuMiX co-cultures involving CCD-18Co cells. After the assembly and priming of the 
HuMiX device, the CCD-18Co cells were inoculated in the human microchamber and 
supplied with fresh DMEM medium (supplemented with 20% FBS and 1% PS) via 600 
simultaneous perfusion in the microbial and the perfusion chamber. After 7 days of culture, 
the device was disassembled, CCD-18Co cells attached to the membrane were stained with 
Alexa Flour 568 Phalloidin and DAPI and the cells on the membrane were subsequently 
visualized using fluorescence microscopy for evaluating the growth and viability 
(Supplementary Figure 4a,b). 605 
 
HuMiX co-cultures involving primary immune cells and LGG. To initiate the co-culture, 
5 x 106 primary human CD4+ T cells were inoculated in the perfusion microchamber 
(Supplementary Figure 4c) and 24 h later LGG (OD ~ 1) was inoculated in the microbial 
microchamber (Supplementary Figure 4e). Both cell types were then co-cultured for another 610 
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24 h. The perfusion and the microbial microchamber were perfused with either oxic or anoxic 
DMEM medium for 48 h, respectively. The viability of the CD4+ T cells, either cultured 
solely (Supplementary Figure 4c,d), or cultured in presence of LGG (Supplementary Figure 
4e,f) had been analyzed using the LIVE/DEAD fixable near IR cell kit (Molecular Probes) 
and flow cytometry. 615 
 
Oxygen sensing. The integrated optical sensors (optodes) allowed for continuous, non-
invasive and non-cytotoxic detection of oxygen levels in the HuMiX device (Figs. 1a and 
Supplementary Figure 1c). The 5 mm diameter pst3 optodes (sensitivity of up to 0.03% of 
O2; PreSens) were bonded into the 1.2 mm deep machined pockets by application of 4 μl 620 
silicone adhesive (PreSens) and cured overnight. Optodes were affixed to both PC enclosures 
20 mm adjacent to the inlets and outlets of the perfusion microchamber and microbial 
microchamber, respectively (Figs. 1a and Supplementary Figure 1a). On the outer surface, 
the enclosures housed 4.5 mm deep pockets for attachment of the polymer optical fibers used 
for transmitting the oxygen measurement signals to the recording device (Supplementary 625 
Figure 1c). Importantly, the distance between the optode and sensing head of the optical fiber 
was 0.5 mm as per the manufacturer’s recommendation (PreSens). The oxygen concentration 
was measured every 15 min using an OXY-4 trace oxygen transmitter/recorder (PreSens) and 
logged using the oxy4v2_41FB software (PreSens) using a connected personal computer. 
 630 
Epithelial barrier measurements. As detailed above, a dedicated HuMiX-TEER device was 
fabricated to allow measurement of transepithelial electrical resistance (TEER) using a STX2 
electrode connected to a Millicell® ERS-2 Epithelial Volt-Ohm Meter (EVOM) during cell 
culture trials in HuMiX (Millipore) (Supplementary Figure 1d). For this, double-electrode 
pairs of the chopstick-style STX2 electrodes (Millipore) were introduced into the perfusion 635 
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and microbial microchambers, respectively. Prior to inoculation of the human cells, TEER 
values were recorded to determine the background resistance of the HuMiX device after all 
the channels were filled with DMEM medium. The background TEER was subtracted from 
the readings subsequently to infer the growth curve of Caco-2 cells by following the increase 
in resistance. As the insertion of chopstick electrodes through the side ports can lead to 640 
contamination of the experiment, the TEER measurements were conducted as an endpoint 
assay and related to epithelial cell barrier formation ascertained following immunostaining 
and fluorescence microscopic analyses. The HuMiX-TEER device was in particular used to 
determine the optimal point in time when the cells had differentiated for the subsequent 
inoculation of bacteria into the device. As a reference, Caco-2 cells were also inoculated in 645 
the standard Transwell systems and supplied with antibiotic-free DMEM medium analogous 
to the cultivation conditions in HuMiX. Here again, the background TEER was also 
measured in Transwell inserts prior to inoculation with Caco-2 cells and later subtracted from 
the actual TEER readings. 
 650 
Cytokine profiling of eluate samples. In order to assess possible immunological responses 
of the epithelial cells to the co-cultured bacteria, 150−200 μl of eluate samples were collected 
from the perfusion microchamber, flash-frozen and preserved at -80°C until further analysis. 
50 μl of the eluates collected from the perfusion microchamber before and after inoculation 
with LGG were analysed for 8 different cytokines using a Human Premixed Multi-Analyte 655 
Kit (R&D Systems Europe; United Kingdom) in combination with the multiplex reader 
MAGPIX (Luminex) accordingly to the manufacturers’ instructions. The kit allowed 
screening for the following human cytokines of interest: CXCL8/IL-8, CCL20/MIP-3 alpha, 
GM-CSF, IL-1 beta, IL-6, IL-10, IL-12p70 and TNF-alpha. Only CCL20 and IL-8 were 
detectable in the samples. 660 
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Sampling of cellular material post culture. 24 h following the initiation of co-culture of 
Caco-2 cells with LGG or LGG and B. caccae, perfusion of the device was stopped and the 
device was disassembled using a manual screwdriver. The gasket-membrane assemblies 
bearing the cells (Caco-2 or LGG or LGG and B. caccae) were then cut into 2 halves: one 665 
half was used for comprehensive biomolecular extractions and the other half for staining and 
microscopic inspection.  
 
Live-dead analyses. Live-dead staining was performed for determining Caco-2 and bacterial 
cell viability. The Calbiochem kit (Millipore) was used on the microporous membranes 670 
containing the Caco-2 cells whereas the BacLight® microbial viability kit (Molecular Probes) 
was applied to the nanoporous membranes containing LGG or LGG and B. caccae. Before 
staining the membrane-bound Caco-2 cells, the membranes were separated from the gaskets 
using tweezers. 200 μl of staining buffer from the Calbiochem kit was then applied to one 
quarter of the membranes and incubated at 37°C for 15 min. For microbial staining and 675 
visualization, one quarter of the membranes were stained using the L7007 BacLight® 
microbial viability kit (Molecular Probes). 200 μl of staining solution were prepared as per 
the manufacturer’s recommendation and applied to the gaskets followed by incubation at 
37°C for 15 min. After removal of the staining buffer, the unbound stains were removed by 
washing of the membrane-bound human and microbial cells with 1 x phosphate buffer saline 680 
(PBS) solution at pH 7.2. The stained cells on the membranes were then fixed in a 4% 
paraformaldehyde (PFA) / 1 x PBS solution for 10 min at room temperature in the dark. After 
an additional wash in 1x PBS, the fixed membranes were mounted on microscope slides 
using ProLong Gold anti-fading mounting medium (Life Technologies Europe). The 
microscope slides were then allowed to dry overnight at room temperature in the dark and 685 
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observed at appropriate excitation wavelengths using a Zeiss 710 Meta confocal laser 
scanning microscope in order to evaluate the morphology and viability of the cells. 
 
Fluorescence microscopic analysis of co-cultured cell contingents. Apart from live-dead 
staining, the membrane-bound human and microbial cells were also stained with specific 690 
dyes and analyzed by fluorescence microscopy. For the detection of occludin, a quarter of the 
microporous membranes covered by the Caco-2 cells were fixed in a 4% (v/v) PFA/PBS 
solution for 10 min at room temperature, washed with 1 x PBS and then blocked for 15 min 
with 5% bovine serum albumin (BSA; Sigma-Aldrich) in 1 x PBS. The cells were then 
stained with anti-Occludin mAb Mouse Alexa Fluor® 488 conjugate (Life Technologies 695 
Europe) diluted 1/200 in 1% (v/v) BSA/PBS solution for 30 min at room temperature in the 
dark. Subsequently, the membrane-bound cells were washed 3 times with 1 x PBS to remove 
unbound fluorescently labeled antibodies. For staining the Caco-2 cell nuclei, 200 μl of 
Hoechst stain (Life Technologies Europe) diluted 1:1000 in 1% (v/v) BSA/PBS solution were 
applied to the cells and incubated for 2 min at room temperature in the dark. After 3 700 
consecutive washes in 1 x PBS, excess solution was removed and the membranes were 
mounted on a microscope slide using ProLong Antifade Reagent (Life Technologies Europe). 
The microscope slides were then allowed to dry overnight at room temperature in the dark 
and observed at appropriate excitation wavelengths using a Zeiss 710 Meta confocal laser 
scanning microscope to visualize cell nuclei and tight junctions. 705 
 The membrane-bound LGG or LGG and B. caccae cells were fixed by application of 
4% (v/v) PFA/PBS solution at RT for 10 min. After 3 washes in 1 x PBS to remove excess 
fixing solution, the membranes were incubated in the dark for 5 min at RT in 1:1000 Hoechst 
/ PBS solution. After a wash in a 1 x PBS to remove excess staining solution, the membranes 
 
 
31
were mounted on microscope slides using the ProLong Antifade Reagent (Life Technologies 710 
Europe) and the cells were visualized using a Zeiss 710 Meta confocal microscope. 
 
Microscopic image processing. Confocal image z-stacks were acquired using the Zeiss Zen 
Black software suite. Z-stacks were processed using Imaris 8 (Bitplane AG) coupled to the 
AutoQuant suite (x 3.0.0, Media Cybernetics) for background correction. 715 
 
Biomolecular extractions. For biomolecular extractions on the adherent Caco-2 cells, the 
gasket-membrane assemblies were first washed in a 0.9% (w/v) NaCl solution. The cells 
were then immediately treated with 800 μl of an ice-cold 1:1 methanol:water (v/v) solution. 
Subsequently, the cells were disrupted and detached from the membranes using a plastic 720 
scrapper (VWR). The methanol:water suspension containing cells was then placed into a 2 ml 
sample tube and 400 μl of ice-cold chloroform were added. The sample mixtures were briefly 
vortexed and centrifuged at 14,000 rpm (21,475 xg) for 5 min at 4 °C to separate the polar 
and non-polar metabolite phases and to concentrate the interphase pellets which were 
subsequently used for the extraction of biomacromolecules (RNA, DNA and proteins)36. The 725 
Caco-2 interphase pellets were then processed using the Qiagen AllPrep DNA/RNA/Protein 
Mini Kit36. The fractions of DNA, RNA and proteins fractions were sequentially isolated and 
snap frozen. All extracts (except DNA fractions) were preserved at -80°C until further 
analysis.  
For the biomolecular extractions on the microbial cell contingents, the microbial cells 730 
were immediately disrupted and detached from the semi-permeable membranes using a 
plastic scrapper (VWR) and placed in a 0.9% (w/v) NaCl solution. This solution was then 
placed in a 2 ml sample tube and centrifuged at 4,000 rpm (1,753 xg) for 10 min at 4 °C to 
pellet the bacteria. The supernatant was discarded and the bacterial pellet was snap-frozen. 
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The bacterial pellet was then lysed using a Precellys lysis kit and polar and non-polar 735 
metabolites fractions were obtained36. The interphase pellet was subsequently used for the 
extraction of biomolecules (RNA, DNA and proteins)36. The bacterial consortium structures 
were resolved by amplifying the V4 region of the 16S rRNA gene using primers 515F and 
805R (515F_GTGBCAGCMGCCGCGGTAA; 
805R_GACTACHVGGGTATCTAATCC)59,60 to quantify the relative abundances of the two 740 
bacterial species. Resultant sequences were analyzed using 16S Metagenomics app on the 
Illumina basespace. 
 The intracellular (Caco-2 and bacteria) polar metabolite fractions were then prepared 
for GC-MS analyses by pipetting 2 x 300 μl of polar fractions into 0.5 ml glass vials 
(Chromatographie Zubehör Trott) and dried using a speedvac. All vials were capped and 745 
stored at -80°C until GC-MS analyses.  
 
Metabolomic analyses. Metabolites derivatization was performed by using a multipurpose 
sampler (Gerstel). Dried polar metabolite extracts from the Caco-2 cells, LGG or LGG and B. 
caccae were dissolved in 15 µl pyridine, containing 20 mg/ml methoxyamine hydrochloride, 750 
at 40 °C for 60 min while shaking. Following the addition of 15 µl N-methyl-N-
trimethylsilyl-triflouroacetamide (MSTFA), the samples were incubated at 40 °C for 30 min 
under continuous shaking. GC-MS analyses were performed using an Agilent 7890A GC 
coupled to an Agilent 5975C mass selective detector (MSD). A sample volume of 1 µl was 
injected into a split/splitless inlet operating in split (3:1) or splitless mode at 270 °C. The gas 755 
chromatograph was equipped with a 30 m DB-35MS capillary column and a 5 m DuraGuard 
capillary in front of the analytical column. Helium was used as the carrier gas with a constant 
flow rate of 1.0 ml/min. The GC oven temperature was kept constant at 80 °C for 6 min and 
then increased to 300 °C at 6 °C/min. After 10 min, the temperature was increased at a rate of 
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10 °C/min followed by a constant temperature period at 325 °C for 4 min. The total run time 760 
was 60 min. The transfer line temperature was set to constant 280 °C. The MSD was 
operating under electron ionization at 70 eV. The MS source was held at 230 °C and the 
quadrupole at 150 °C. Full scan mass spectra were acquired from m/z 70 to m/z 800. An 
alkane mix was run with every experimental sequence in order to provide retention index 
calibration for the experimental samples. All GC-MS chromatograms were processed using 765 
the MetaboliteDetector software61.  
 
Microarray analyses. RNA extracts were prepared using the Affymetrix WT PLUS Reagent 
Kit (Affymetrix). RNA quality and quantity was checked using a 2100 Agilent Bioanalyzer 
(Agilent) and a NanoDrop (Thermo Scientific), respectively. For gene expression analysis, 770 
100 ng of total RNA were used in conjunction with the Affymetrix standard protocol for 
Human Transcriptome Arrays 2.0 (Affymetrix Inc.). For the miRNAs analysis, 1µg of total 
RNA was analyzed using the FlashTag Biotin HSR RNA labeling kit for the Affymetrix 
Genechips miRNA 4.0 microarrays (Affymetrix Inc.). 
 775 
RT-qPCR validation of selected differentially expressed genes. Total RNA was extracted 
from Caco-2 cells co-cultured with LGG grown under anaerobic conditions in the HuMiX 
device as well as from Caco-2 cells grown under control conditions (Supplementary Figure 3) 
using the Qiagen AllPrep DNA/RNA/Protein Mini Kit (Qiagen). cDNA synthesis was carried 
out on the extracted total RNA using the SuperScript III First-Strand Synthesis System (Life 780 
Technologies Europe). Equal amounts of cDNA were amplified in combination with 
sequence-specific forward and reverse primers (Eurogentec). The amplification reaction took 
place in a total volume of 20 µl of reaction mixture whereby primers (Supplementary Table 
11) were added at a concentration of 10 µM, 10 µl of iQ SYBR Green Supermix (Bio-Rad) 
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and the remaining volume was adjusted for cDNA amount and water. In order to normalize 785 
the mRNA expression for each analysed sample, the human house-keeping gene L27 was 
amplified using the same reaction conditions. Real-time PCR was carried out on a 
LightCycler® 480 Real-Time PCR System (Roche) using a denaturation step of 95 o C for 3 
min followed by 45 cycles of 95 o C for 30 sec, 60 o C for 30 sec and 72 o C for 30 sec, 
respectively. Ct values were obtained using automatic baseline and threshold settings 790 
provided by the LightCycler® 480 Software, Version 1.5. Data were analysed and normalized 
using the “advanced relative quantification” method. Individual targets were analysed in 
three biological replicates and represented as a mean. Statistical significance was calculated 
using a paired Student’s t-test. 
 795 
Data analyses. The microarray gene expression data was pre-processed using the GC-RMA 
procedure for background correction, quantile normalization and probe replicate 
summarization implemented in the gcrma R-package62. All statistical analyses were 
performed in the R Statistical Programming Environment63 and all differential expression 
analyses were carried out using the R-package limma64. Differential expression of genes 800 
between anaerobic co-cultures, aerobic co-cultures and their corresponding control samples 
were analyzed using the empirical Bayes moderated t-statistic65. In order to account both for 
significance and effect size, the final ranking of genes was determined using the pi-value, a 
statistic combining the p-value significance and log-fold-change into a single score66. Only 
genes with known functional annotations were considered for further analysis. Genes with 805 
opposing alteration patterns between co-culture and control samples under the different 
experimental conditions (Supplementary Figure 3) were identified and scored as follows: 
First, the pi-value for differential expression between co-culture and control samples was 
determined for each gene as described above, once for anaerobic samples and once for 
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aerobic samples. Next, the genes in the two pi-value rankings were filtered, such that only 810 
genes for which the sign of the log-fold-change differed between anaerobic and aerobic 
samples were retained. The final ranking for these genes was obtained from the sum of ranks 
for the two pi-value rankings (i.e. sorting the genes by decreasing pi-values for both 
anaerobic and aerobic samples and summing up the ranks for each gene). Genes with shared 
expression profiles were determined analogously, only changing the above procedure by 815 
filtering such that only genes were retained for which the sign of the logarithmic fold change 
(log-fold-change) was the same for anaerobic and aerobic samples. 
 For the analysis of altered cellular pathways, the GeneGo MetaCore™ software suite 
was used with the differential expression statistics from the empirical Bayes moderated t-
statistic as input (see details above). The genes were pre-filtered using a p-value significance 820 
threshold (P < 0.05) before applying the GeneGO analysis. In order to investigate the global 
gene expression alterations in biological processes of the Gene Ontology (GO) database, we 
determined all GO processes covered by at least 10 genes in the microarray dataset and 
computed the median gene expression levels across process members for each of these GO 
processes. Significantly altered processes were then determined by applying the empirical 825 
Bayes moderated t-statistic again.  
Finally, to visualize the expression of the genes or levels of the metabolites in the 
different experimental conditions, heatmaps and dendrogram visualizations were generated 
using the gplots R-package (http://cran.r-project.org/web/packages/gplots) and an average 
linkage hierarchical clustering with the Euclidean distance metric to determine the ordering 830 
of genes and metabolites. Gene expression measurements were converted to Z-scores and 
visualized by a color gradient, where blue colors represent lower Z-scores and yellow colors 
stand for higher Z-scores (the color darkness in each heatmap is proportional to the absolute 
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Z-score). A different color scheme was used for the metabolite plots (Light blue and pink). 
All box plots were created using the standard R boxplot function67–69. 835 
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Figures 
Figure 1 ⏐ The HuMiX model. (a) Conceptual diagram of the HuMiX model for the 
representative co-culture of human epithelial cells with gastrointestinal microbiota. (b) 
Annotated exploded view of the HuMiX device. The device is composed of a modular stacked 1055 
assembly of elastomeric gaskets (thickness: 700 μm) sandwiched between two polycarbonate 
(PC) enclosures, and each gasket defines a distinct spiral-shaped microchannel with the 
following characteristics: length of 200 mm, width of 4 mm and height of 0.5 mm, amounting 
to a total volume of 400 μl per channel. Semi-permeable membranes affixed to the 
elastomeric gaskets demarcate the channels. The pore sizes of the membranes were chosen for 1060 
their intended functionality. A microporous membrane (pore diameter of 1 μm), which allows 
diffusion-dominant perfusion to the human cells, is used to partition the perfusion and human 
microchambers. A nanoporous membrane (pore diameter of 50 nm) partitions the human and 
microbial microchambers to prevent the infiltration of microorganisms, including viruses, into 
the human microchamber. (c) Photograph of the assembled HuMiX device (Scale bar: 1 cm). 1065 
(d) Diagram of the experimental setup of the HuMiX model with provisions for the perfusion 
of dedicated oxic and anoxic culture media as well as the monitoring of the oxygen 
concentrations and transepithelial electrical resistance. The oxygen concentration in the 
anoxic medium is maintained at 0.1% by continuously bubbling the medium with dinitrogen 
gas. (e) Diagrammatic overview of the HuMiX co-culture protocol.  1070 
 
Figure 2 ⏐ In vitro co-culture of human and microbial cells inside the HuMiX device. (a) 
Characterization of epithelial cell monolayer formation in HuMiX in comparison to the 
standard Transwell system. In both cases, the transepithelial electrical resistance (TEER) 
was determined on 7 day-old Caco-2 cell layers using standard chopstick electrodes. The error 1075 
bars indicate the standard errors of the mean (n=3). * indicates a statistically significant 
difference (paired Student’s t-test, p < 0.05). (b) Immunofluorescent microscopic observation 
of the tight-junction protein occludin (green) in Caco-2 cells following 24 h of co-culture with 
LGG grown under anaerobic conditions. The cell nuclei are stained with DAPI and appear in 
blue. (c) and (d) Viability assessment of Caco-2 cells and LGG at 24 h post co-culture, 1080 
respectively. The cells were stained using a live-dead stain and observed using a fluorescence 
microscope. The live cells appear in green, whereas the dead cells appear in red. The mucin-
coated nanoporous membrane provides a surface for the attachment and subsequent 
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proliferation of the bacteria, whereas the collagen-coated microporous membrane does 
support the attachment and proliferation of the Caco-2 cells. (e) Representative 1085 
electropherogram of an RNA fraction obtained from the Caco-2 cells co-cultured in HuMiX. 
The RNA Integrity Number (RIN) is provided. (f) Sampled eluates from the HuMiX device 
following a 24 h co-culture with LGG. (g) Oxygen concentration profiles within the perfusion 
and microbial microchambers upon initiation of the co-culture with LGG.  indicates the pre-
inoculation oxygen concentration of 2.6% in the microbial microchamber. (h) The relative 1090 
abundances (in %) of Lactobacillus spp. and Bacteroides spp. following 24 h of co-culture 
with Caco-2 cells determined by 16S rRNA gene amplicon sequencing (n = 4). (Scale bars in 
(b), (c) and (d): 10 μm.)  
 
Figure 3 ⏐ Validation of the HuMiX model by transcriptomic, metabolomic and 1095 
immunological analyses of Caco-2 cells co-cultured with LGG grown under anaerobic 
conditions. (a) Heatmap highlighting the top 30 differentially expressed genes and miRNAs 
in Caco-2 cells co-cultured with LGG growing under anaerobic conditions compared to their 
corresponding LGG-free controls (n = 3). The threshold parameters used were FC > 2 and P < 
0.01, as determined using the empirical Bayes moderated t-statistic65. Ranking was based on 1100 
the pi-values calculated using the log-fold changes and p-values (BtS). An average linkage 
hierarchical clustering with the Euclidean distance metric was performed to determine the 
ordering of the genes. (b) Extracellular CCL20/MIP3A and IL-8 cytokine levels before and 
24 h after the initiation of co-culture with LGG. Eluate samples were obtained from the 
perfusion microchamber (n = 3). (c) Heatmap of intracellular metabolites from Caco-2 cells 1105 
co-cultured with LGG growing under anaerobic conditions compared with their 
corresponding LGG-free controls (n = 3). The threshold parameter used was P < 0.1 (StT). An 
average linkage hierarchical clustering with the Euclidean distance metric was performed to 
determine the ordering of the metabolites. 
Figure 4 ⏐ Comparison of the transcriptional and metabolic changes induced in the 1110 
Caco-2 cells following their co-culture with a consortium of LGG and B. caccae grown 
under anaerobic conditions. (a) Heatmap highlighting the top 30 differentially expressed 
genes and miRNAs in Caco-2 cells co-cultured with either LGG alone or LGG and B. caccae 
growing under anaerobic conditions compared with their bacteria-free controls (n = 3). The 
threshold parameters used were FC > 2 and P < 0.01, as determined using the empirical 1115 
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Bayes moderated t-statistic65. Ranking was based on the pi-values calculated using the log-
fold changes and p-values (BtS). An average linkage hierarchical clustering with the 
Euclidean distance metric was performed to determine the ordering of the genes. (b) Venn 
diagram comparing the gene expression patterns obtained when Caco-2 cells were co-cultured 
with LGG or with a consortium of LGG and B. caccae growing under anaerobic conditions. 1120 
The threshold parameters used were FC > 1.5 and P < 0.01 (BtS). (c) Heatmap of intracellular 
metabolites from Caco-2 cells co-cultured with LGG and B. caccae growing under anaerobic 
conditions in comparison to monocultures of Caco-2 cells for which anaerobic medium was 
perfused through the microbial microchamber. The threshold parameter used was P < 0.1 
(StT). An average linkage hierarchical clustering with the Euclidean distance metric was 1125 
performed to determine the ordering of the metabolites. 
Figure 5 ⏐ Transcriptional responses of Caco-2 cells that exhibited opposite responses 
following co-cultures with LGG grown under either anaerobic or aerobic conditions. (a) 
Heatmap representing the top 30 Caco-2 genes and miRNAs that exhibit opposite expression 
patterns in Caco-2 cells when co-cultured with LGG growing under either anaerobic or 1130 
aerobic conditions compared with their respective LGG-free controls. The ranking was based 
on the pi-values calculated using log-fold changes and p-values (BtS). An average linkage 
hierarchical clustering with the Euclidean distance metric was performed to determine the 
ordering of the genes. (b) Venn diagram comparing the gene expression patterns of Caco-2 
cells obtained when LGG was growing under anaerobic and aerobic conditions. The threshold 1135 
parameters used were FC > 1.5 and P < 0.01 (BtS).  
 
Figure 6 ⏐ Microarray-based miRNA expression analysis of Caco-2 cells co-cultured 
with LGG, LGG and B. caccae, and their corresponding bacteria-free controls. Heatmap 
of the top 30 statistically significant differentially expressed genes are highlighted. The 1140 
threshold parameters used were FC > 1.5 and P < 0.05 (BtS). An average linkage hierarchical 
clustering with the Euclidean distance metric was performed to determine the ordering of the 
genes. 
 
 
48
Table 1 ⏐ Differentially expressed genes in Caco-2 cells following their HuMiX-based co-culture with LGG in comparison to in vivo data. 
References indicating the functions of the highlighted genes are provided in Supplementary Table 12. (GF = germ-free). 1145 
Gene 
In vitro HuMiX-based co-cultures In vivo data 
Function LGG 
culture 
conditions 
Expression log FC P-value Subject Expression Ref 
EGR1 
Only 
differentially 
expressed 
when LGG 
growing 
under 
anaerobic 
conditions 
 
Down -2.56 0.0012 Human Down 33 
Transcription regulation, transcription factor activity 
for the regulation of cell proliferation and apoptosis, 
anti-cancer effect and IL-8 suppression 
 
CCL2 Up +1.51 0.0005 Human Up 32 
Chemotactic factor that attracts monocytes and 
basophils and binds to the chemokine receptors 
CCR2 and CCR4 
 
SLC9A1 Down -0.29 0.0168 Human Down 32 
Signal transduction, regulation of pH homeostasis, 
cell migration, cell volume, and anti-inflammatory 
effect 
UBD Up +0.61 0.0261 Human Up 33 Proteasomal degradation, cytokine response, antimicrobial response, and apoptosis 
ELF3 Differentially 
expressed 
when LGG 
growing 
under both 
anaerobic 
and aerobic 
conditions 
 
 
Up +0.55 0.0022 Human & GF Piglet Down 
33,34 
ets family member, epithelial-specific function, 
transcriptional mediator of angiogenesis during 
inflammation and epithelial cell differentiation 
 
CXCR4 Up +0.94 0.0019 Human Up 33 
Chemotaxis, cell arrest, angiogenesis, cell survival, 
maintenance of the epithelial barrier function and 
HIV-1 co-receptor 
MYBL2 Down -0.26 0.0446 Human Down 33 Anti-apoptopic function, regulation of cell cycle and transcription, and epithelial cell differentiation 
PIM1 Up +1.13 0.0039 Human Up 32 Cell survival, cell proliferation, cell growth, and signal transduction 
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CYP1A1 Up +0.82 0.0090 Human Up 33 Drug metabolism and xenobiotic transformation 
GADD45B Up +0.60 0.0134 Human Down 33 Cell growth and apoptosis 
PILRB Down -0.45 0.0374 Human Up 33 Receptors involved in the regulation of the immune system and cellular signaling 
CDK9 Down -0.22 0.0467 Human Up 33 Cell proliferation, regulation of the cell cycle, and transcription elongation factor 
SOX4 
Only 
differentially 
expressed 
when LGG 
growing 
under 
anaerobic 
conditions 
Down -0.31 0.0295 GF piglet Unspecified 34 
Transcription factor, regulation of cell fate and 
apoptosis pathway, and prognostic marker in colon 
and gastric cancer  
CEBPA Up +0.55 0.0172 GF piglet Unspecified 34 Transcription factor, cell cycle regulation, and regulation of metallothioneins 
PTGS2 Up +1.13 0.0145 GF piglet Down 34 Prostaglandin biosynthesis and metabolism, inflammation, and mitogenesis 
IGFBP2 Up +0.5 0.015 GF piglet Up 34 Regulation of IGF-mediated growth and developmental rates 
GSTA1 Down -0.5 0.005 GF piglet Down 34 Detoxification of carcinogens, drugs, environmental toxins, and products of oxidative stress 
CTNNB1 Up +0.54 0.003 GF piglet Up 34 Regulation of cell growth in addition to the creation and maintenance of epithelial layers 
TPD52 Up +0.42 0.008 GF piglet Up 34 Molecular marker in human cancer, and target for immunotherapy 
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